Insilico and Qilu partner to create generative AI cardiometabolic drugs Drug Target Review
Source Credit: https://news.google.com/rss/articles/CBMiuAFBVV95cUxPckNjZklLLXR5d1BENnNXbGFQenFUQ1NZZUpqRjFJUHYxSWczSWtCcUgtQkxjV28wVzBYYlNQVDc1MXVXR0RRVWhnSEM4clowU3EtMzJJbVUwdjVrSVg4TV8wcmhUX1FVYlpubGs5Z190UWh2ejljX2JyQlN4eE1EUTdKVU5BUmpFOWZFRWhFUzFta2NNTkFSbWVaQlMzRnJ1ZHFJbjNBTy1zU2FseXFYaHBSd2RYcUtZ?oc=5
About the Author
